findmyKOL
Clinical trialNCT00104299CompletedPhase 2/PHASE3Interventional

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment197Microscopic PolyangiitisVasculitisWegener's Granulomatosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Netherlands
  • University Hospital Groningen

    Groningen, Netherlands

United States
  • University of Alabama

    Birmingham, Alabama, United States

  • Johns Hopkins University

    Baltimore, Maryland, United States

  • Boston University

    Boston, Massachusetts, United States

  • Mayo Clinic Foundation

    Rochester, Minnesota, United States

  • Hospital for Special Surgery

    New York, New York, United States

  • Duke University

    Durham, North Carolina, United States

  • the Cleveland Clinic

    Cleveland, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2005
Primary completion
31 Dec 2008
Completion
31 Jan 2010
Last update posted
21 Apr 2017
Registered enrollment
197
Registry id
NCT00104299

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.